SOURCE: Synergetics USA, Inc.

Synergetics USA, Inc.

March 20, 2015 11:00 ET

Synergetics USA to Participate in Morgan Stanley Healthcare Corporate Access Day

O'FALLON, MO--(Marketwired - Mar 20, 2015) - Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced its upcoming participation in the 2015 Morgan Stanley Healthcare Corporate Access Day on Wednesday, April 1st at The Langham Hotel in Boston, Massachusetts.

David Hable, President and Chief Executive Officer and Pamela Boone, Executive Vice President and Chief Financial Officer will be available to meet with investors beginning at 8:45 a.m. ET. There will be no formal presentation.

About Synergetics USA, Inc.

Synergetics USA, Inc. ("Synergetics USA" or the "Company") is a leading supplier of precision surgical devices. The Company's primary focus is on the surgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits, and the delivery of various energy modalities for the performance of less invasive surgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company's website address is

Contact Information

    3845 Corporate Centre Drive
    O'Fallon, Missouri 63368
    (636) 939-5100
    Pamela G. Boone
    Chief Financial Officer